MAGDALENA CHERUBIN: Open Payments
NPI 1649655622 · STANFORD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,502 in 12 payments from 9 companies in 2025. Trend: 2023 $125 · 2024 $247 · 2025 $1,502
Food & beverage: $1,502
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 2 | $254 |
| Lilly USA, LLC | 2 | $238 |
| Radius Health, Inc. | 2 | $219 |
| Abbott Laboratories | 1 | $176 |
| Dexcom, Inc. | 1 | $153 |
| Insulet Corporation | 1 | $149 |
| Sequel Med Tech, LLC | 1 | $145 |
| BETA BIONICS, INC. | 1 | $121 |
| Mannkind Corporation | 1 | $47 |
Products named: MINIMED 780G, Tymlos, FREESTYLE LIBRE 3, Dexcom G6 Transmitter, OMNIPOD, TWIIST, ZEPBOUND, iLet Bionic Pancreas.
Industry payments across CA — which companies pay providers there.
